← Back to Search

Advanced Rehabilitation Technology for Neurological Disorders

N/A
Recruiting
Led By Brett Schoen, MD
Research Sponsored by Rehabilitation Hospital of Overland Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial compares using robotic devices & advanced tech with traditional rehab to improve outcomes for people w/ neurological diagnoses and save money.

Who is the study for?
This trial is for adults over 18 with neurological disorders who are in inpatient rehab and can stay at least 7 days. They must be able to communicate, follow commands, fit into a device, and tolerate certain positions. Excluded are those with conditions limiting study benefits or involved in another study.
What is being tested?
The study tests if using robotic devices like Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics during rehab gives similar or better results than standard therapy alone. It's randomized: some get technology-assisted therapy; others don't.
What are the potential side effects?
Potential side effects may include discomfort from fitting into the devices or fatigue due to increased intensity of rehabilitation sessions. There might also be risks specific to each device used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Neuro-QOL
Secondary study objectives
10 Meter Walk Test
Areas of pain
Cost of caregiver burden
+13 more
Other study objectives
Goal attainment scale (GAS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Inpatient Rehabilitation with ARTExperimental Treatment1 Intervention
Inpatient rehabilitation with advanced rehabilitation technology
Group II: Inpatient Rehabilitation without ARTActive Control1 Intervention
Inpatient rehabilitation without advanced rehabilitation technology

Find a Location

Who is running the clinical trial?

Rehabilitation Hospital of Overland ParkLead Sponsor
Discovery StatisticsUNKNOWN
Brett Schoen, MDPrincipal InvestigatorRehabilitation Hospital of Overland Park

Media Library

Inpatient Rehabilitation with ART Clinical Trial Eligibility Overview. Trial Name: NCT05652946 — N/A
Neurological Disorders Research Study Groups: Inpatient Rehabilitation with ART, Inpatient Rehabilitation without ART
Neurological Disorders Clinical Trial 2023: Inpatient Rehabilitation with ART Highlights & Side Effects. Trial Name: NCT05652946 — N/A
Inpatient Rehabilitation with ART 2023 Treatment Timeline for Medical Study. Trial Name: NCT05652946 — N/A
~65 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top